Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
暂无分享,去创建一个
Tomasz Stokowy | Steffen Hauptmann | Michal Jarzab | Barbara Jarzab | Michal Swierniak | Ralf Paschke | R. Paschke | S. Hauptmann | E. Chmielik | M. Eszlinger | B. Wojtaś | Dagmara Rusinek | A. Pfeifer | B. Jarzab | M. Jarzab | T. Musholt | Ewa Chmielik | Agnieszka Czarniecka | Jolanta Krajewska | Aleksandra Kukulska | Dariusz Lange | Dagmara Rusinek | Markus Eszlinger | T. Stokowy | T. Tyszkiewicz | Malgorzata Oczko-Wojciechowska | M. Świerniak | D. Lange | J. Krajewska | M. Oczko-Wojciechowska | A. Czarniecka | E. Stobiecka | A. Kukulska | Monika Halczok | Bartosz Wojtas | Aleksandra Pfeifer | Thomas Musholt | Ewa Stobiecka | Tomasz Tyszkiewicz | Monika Halczok | M. Jarząb
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] Kikuya Kato,et al. Differentiation of Follicular Thyroid Adenoma from Carcinoma by Means of Gene Expression Profiling with Adapter-Tagged Competitive Polymerase Chain Reaction , 2005, Oncology.
[3] M. Nagano,et al. The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia , 2013, PloS one.
[4] R. Parameswaran,et al. Molecular pathogenesis of follicular cell derived thyroid cancers. , 2010, International journal of surgery.
[5] Jennifer Shoemaker,et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. , 2004, The Journal of clinical investigation.
[6] R. Vassilopoulou-sellin,et al. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. , 1998, The American journal of surgical pathology.
[7] G. Lozano,et al. Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. , 2011, Human pathology.
[8] N. Eberhardt,et al. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. , 2005, The Journal of clinical endocrinology and metabolism.
[9] R. Paschke,et al. Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling. , 2013, Endokrynologia Polska.
[10] S. Liyanarachchi,et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Z. Baloch,et al. Follicular-Patterned Tumors of the Thyroid: The Battle of Benign vs. Malignant vs. So-called Uncertain , 2011, Endocrine pathology.
[12] N. Socci,et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.
[13] T. Fahey,et al. Molecular analysis of minimally invasive follicular carcinomas by gene profiling. , 2005, Surgery.
[14] Anne-Laure Boulesteix,et al. CMA – a comprehensive Bioconductor package for supervised classification with high dimensional data , 2008, BMC Bioinformatics.
[15] Ed Y. Tom,et al. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules? , 2013, The Journal of clinical endocrinology and metabolism.
[16] Philippe Vielh,et al. Gene Expression Profiling of Differentiated Thyroid Neoplasms , 2004, Clinical Cancer Research.
[17] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[18] F. Bertucci,et al. Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. , 2004, The Journal of clinical endocrinology and metabolism.
[19] Olivier Elemento,et al. A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration , 2012, Clinical Cancer Research.
[20] A. Miyauchi,et al. Gene expression profiles in thyroid carcinomas , 2000, British Journal of Cancer.
[21] F. Fang,et al. The Expression of Activin Receptor–Like Kinase 1 among Patients with Head and Neck Cancer , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[22] C. Barden,et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] T. Fahey. Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination , 2006 .
[24] Adam L. Asare,et al. Power enhancement via multivariate outlier testing with gene expression arrays , 2009, Bioinform..
[25] Richard Simon,et al. Bias in error estimation when using cross-validation for model selection , 2006, BMC Bioinformatics.
[26] T. Takano,et al. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas , 2004, British Journal of Cancer.
[27] L. Adan,et al. Use of molecular markers in samples obtained from preoperative aspiration of thyroid. , 2012, Endocrine journal.
[28] B. Wojtaś,et al. Somatic mutation profiling of follicular thyroid cancer by next generation sequencing , 2016, Molecular and Cellular Endocrinology.
[29] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[30] Holger Moch,et al. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. , 2008, Oncology reports.
[31] R. Paschke,et al. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues , 2013, BMC Medical Genomics.
[32] Hanna Göransson,et al. Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors , 2006, Tumor Biology.
[33] A. Vargas,et al. Tumor Heterogeneity in a Follicular Carcinoma of Thyroid: a Study by Comparative Genomic Hybridization , 2011, Endocrine pathology.
[34] M. Yamashina,et al. Follicular Neoplasms of the Thyroid: Total Circumferential Evaluation of the Fibrous Capsule , 1992, The American journal of surgical pathology.
[35] Eric T. Wang,et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. , 2010, The Journal of clinical endocrinology and metabolism.
[36] E. J. Neves,et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression , 2006, Cancer.
[37] M. Hansmann,et al. QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study , 2009, BMC Cancer.
[38] A. Gill,et al. Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas , 2003 .
[39] Ricardo Henao,et al. Molecular signatures of thyroid follicular neoplasia. , 2010, Endocrine-related cancer.
[40] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[41] Krzysztof Fujarewicz,et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. , 2005, Cancer research.
[42] S. Chevret,et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. , 2003, Human pathology.
[43] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[44] Darya Chudova,et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.